Roka Bioscience, Inc. (ROKA) |
|---|
| $0.53 52 Week Low | $3.85 2017-04-28 14:17:55 MDT | $7.37 52 Week High |
| Healthcare Sector | Medical Laboratories Industry |
| Nasdaq Stock Exchange | United States Country |
| Market Cap: | $18,530,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | N/A | Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index. |
ForwardPE: Unknown | 5 Yr Est Growth: 35.00% | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 1.32% | % Above 200 DayMA: -12.30% |
ROKA Performance 52 Weeks: 413.89% | S&P 500 Performance 52 Weeks: 12.50% |
Mixed Trend. Short Term trend is up, but longer term trend is down. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | ROKA outperforming S&P 500 by 401.39% the last 52 Weeks. |
Price To Book: 0.51 | Great Value. Low Price to Book means better value. |
EV to EBITDA: N/A | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | N/A | 17.28% | Unknown. |
| % Held By Institutions | N/A | 62.07% | Unknown. |
| Short % Of Float | 10.63% | 07.02% | Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards. |
| Debt to Equity | 0.16 | 1.08 | More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | -407.10% | -05.28% | Operating Margin less than average percent. Stock can do better than this? |
| Return on Equity % | -75.28% | -08.79% | Return on Equity less than average percent. Stock can do better than this? |
| Return on Assets % | -27.01% | -01.29% | Return on Assets less than average percent. Stock can do better than this? |
| Revenue Per Employee | $80,444.44 | $883,096.70 | Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard. |
| Price to Cash | 0.78 | 5.52 | Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS:
|